This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials.
Diabetes, obesity & metabolism, 26(2), 473-481
Citation
Patel, Hiren; Khunti, Kamlesh; Rodbard, Helena W; Bajaj, Harpreet S; Bray, Ross; Kindracki, Zbigniew; Rodríguez, Ángel. (2024). Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials.. Diabetes, obesity & metabolism, 26(2), 473-481. https://doi.org/10.1111/dom.15333